
RET-IN-8 is a rearranged during transfection (RET) киназы ингибитор extracted from patent WO2021093720A1 compound I-1. RET-IN-8 can be used for the research of cancer.
RET-IN-8 is a rearranged during transfection (RET) kinase inhibitor extracted from patent WO2021093720A1 compound I-1. RET-IN-8 can be used for the research of cancer.
Только для научно-исследовательского применения. Не предназначено для использования у пациентов или в качестве лекарственного средства.